ArticleInfection and drug resistance2026
The HIV/HBV Co‑infection Paradox: Immune Modulation Amid Persistent Risk [Response To Letter].
Renato Bobadilla, Finn MacLean, Shravan Dave, Jason T Blackard, Sara Gianella
Abstract readCommentLetter
In one paragraphArticle in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
5 authors.
Renato BobadillaDivision of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, San Diego, CA, USA.ORCID 0009-0007-2558-7425 Finn MacLeanMedical Scientist Training Program, University of California San Diego, La Jolla, San Diego, CA, USA.
Shravan DaveDivision of Gastroenterology and Hepatology, University of California San Diego, La Jolla, San Diego, CA, USA.
Jason T BlackardDepartment of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Sara GianellaDivision of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, San Diego, CA, USA.
Funding
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1MAIDS Clinical Trials Group NetworkU01AI068636 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI KURITZKES, DANIEL R. · 2006 to 2010
$147.1MVirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SONIA JAIN · 1994 to 2026
$78.4MHOPE Training GrantT32AI007384 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sara Gianella Weibel, Scott L Letendre · 1990 to 2026
$9.7MUC San Diego Medical Scientist Training ProgramT32GM154642 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Neil C Chi, Mary Kathleen Lewinski · 2025 to 2026
$2.9MNIAID NIH HHS P30 AI036214NIAID NIH HHS T32 AI007384NIAID NIH HHS U01 AI068636NIAID NIH HHS UM1 AI068636NIGMS NIH HHS T32 GM154642
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID42158359
PMCPMC13182733
What Socratic holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390